Arbutus Biopharma (ABUS) Free Cash Flow Growth (3y) (2016 - 2026)
Arbutus Biopharma (ABUS) Free Cash Flow Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -5.05% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.07% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.71% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -10.65% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - | 33.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.37% |
| Dec 31, 2025 | 35.10% |
| Sep 30, 2025 | 32.34% |
| Jun 30, 2025 | 8.42% |
| Mar 31, 2025 | -38.41% |
| Dec 31, 2024 | 19.13% |
| Sep 30, 2024 | -8.90% |
| Jun 30, 2024 | 0.31% |
| Mar 31, 2024 | -2.55% |
| Dec 31, 2023 | -4.47% |
| Sep 30, 2023 | -21.43% |
| Jun 30, 2023 | -32.05% |
| Mar 31, 2023 | -21.06% |
| Dec 31, 2022 | -8.48% |
| Sep 30, 2022 | 7.49% |
| Jun 30, 2022 | -4.74% |
| Mar 31, 2022 | 47.92% |
| Dec 31, 2021 | -4.36% |
| Sep 30, 2021 | -6.10% |
| Jun 30, 2021 | 6.73% |